Preventing Disease Emergence Following Eradication: Application to Mpox
Cora HirstiD, Julia DeichmanniD, Ananya SahaiD, Ira M. LonginiiD, Andreas HandeliD, Marc LipsitchiD, Daniel B. WeissmaniD, Rustom AntiaiD
Abstract
We use simple mathematical models to explore the factors that influence the evolutionary emergence of mpox to a pathogen capable of sustained human to human transmission that poses a global threat. Smallpox eradication followed by the discontinuation of immunization with vaccinia has led to a decline in the level of population immunity against related poxviruses such as mpox. This decline in immunity results in an increase in both the number of spillovers and the extent of human to human transmission. We find that increases in transmissibility of mpox between humans have a much greater effect on the probability of evolutionary emergence compared with increases in the number of zoonotic spillovers. We suggest that while mpox only needs to have a reproductive number slightly greater than one to become endemic, subsequent adaptation is likely to further increase its transmissibility in the human population. As a consequence a much higher level of vaccination (or other intervention) is needed to control the pathogen after its evolutionary emergence compared with what is needed to prevent it from emerging in the first place.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 0
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Origins of monkeypox viruses and their strains circulating in 2022
J.-M. Chen, H. Gong, … Y.-X. Sun·bioRxiv·Sep 7, 2022
- Putative APOBEC3 deaminase editing in MPXV as evidence for sustained human transmission since at least 2016.
A. N. O'Toole, R. Neher, … A. Rambaut·bioRxiv·Jan 23, 2023
- Highly efficient anogenital transmission of clade Ia mpox virus associated with increased shedding.
Franziska Karola Kaiser, Reshma Koolaparambil Mukesh, … Vincent Jacobus Munster·bioRxiv·Aug 14, 2025
- Attenuation of the 2022 global outbreak monkeypox virus relative to its clade IIb ancestor
Rebecca P. Sumner, Lucy Eke, … Carlos Maluquer de Motes·bioRxiv·Feb 27, 2025
- A monkeypox mRNA-lipid nanoparticle vaccine targeting virus binding, entry, and transmission drives protection against lethal orthopoxviral challenge
A. W. Freyn, C. Atyeo, … B. Moss·bioRxiv·Dec 17, 2022
- Possible adaption of the 2022 Monkeypox virus to the human host through gene duplication and loss
Annika Brinkmann, Claudia Kohl, … Andreas Nitsche·bioRxiv·Oct 21, 2022